10 research outputs found
Dual-mode regulation of the APC/C by CDK1 and MAPK controls meiosis I progression and fidelity
Dernière mise à jour : 26 août 2015 Il existe plusieurs enregistrements de cette chanson gaillarde de Saint-Gelais, notamment mise en musique par Pierre Certon et Clément Janequin. Parmi ceux-ci, Jacques Feuillie Vocal Group, Libertine songs of the French Renaissance, 1975. Le verger de musique, Antony Auvidis, 1999 (1996). Joël Cohen and The Boston Camerata, Pierre Certon : chansons, Harmonia Mundi, 2008 (1980). Württembergischer Kammerchor, Kurz Dieter, Trink- und Liebeslieder der Renaissa..
Scientific Report 2011-2012
144 p.-MEMORIA DE LA DIRECCION: El Centro de Investigaciones Biológicas (CIB) es uno
de los centros de investigación con mayor prestigio
y tradición en la Agencia Estatal Consejo Superior de
Investigaciones Científicas (CSIC). El CIB ha estado en
la vanguardia de la investigación en Biología desde su creación
en 1953. La actividad inicial del CIB estuvo fundamentalmente
orientada hacia estudios en Biología y Biomedicina pero
actualmente es un Centro multidisciplinar, que agrupa de la Dirección | Director’s Report
investigadores de las áreas de Biología, Ciencias Agrarias y
Químicas. Es un Centro activo y dinámico, en constante evolución.
Durante su larga trayectoria, el CIB ha formado grandes
investigadores que han sido la semilla de otros centros de prestigio
como el Centro de Biología Molecular Severo Ochoa, el Instituto
Cajal y el Instituto de Investigaciones Biomédicas Alberto Sols
en Madrid, el Instituto de Bioquímica Vegetal y Fotosíntesis en
Sevilla y el de Instituto de Microbiología Bioquímica en Salamanca
(actualmente Instituto de Biología Funcional y Genómica).
En la actualidad el CIB acoge alrededor de 560 profesionales
incluyendo investigadores de plantilla, doctores contratados, becarios
y contratados realizando su Tesis Doctoral y otros profesionales
dedicados a la administración y mantenimiento del Centro.
Su ubicación actual, en el Campus de Moncloa, rodeado de las
Facultades de Biología, Física, Química, Farmacia y Medicina y
las Escuelas de Forestales y Agrónomos, nos sitúa en un marco
inigualable para establecer colaboraciones con el ámbito
universitario, participando en cursos de Grado y de Máster para
la formación de jóvenes científicos. Además, el CIB colabora con
diferentes Escuelas para la formación de técnicos cualificados. El
carácter multidisciplinar del CIB lo convierte en una referencia
para la formación de nuevos científicos y técnicos, perfectamente
capacitados para su integración en los laboratorios de las mejores
instituciones internacionales y empresas.
La financiación necesaria para las investigaciones realizadas
en nuestro Centro se obtiene de diferentes agencias, tanto
internacionales como nacionales, mediante concursos competitivos,
así como de contratos con empresas. El CIB lleva a cabo además un
importante papel en la transferencia de conocimiento, poniendo a
disposición de la sociedad los resultados de la investigación científica
mediante la generación de patentes, que recogen los logros del
CIB en diferentes campos como el diseño de nuevos abordajes
terapéuticos, vacunas, ensayos biológicos o procedimientos para
el desarrollo biotecnológico o industrial. Además, en el CIB se han
creado dos empresas de base tecnológica (spin-off) para potenciar el
desarrollo tecnológico de estas investigaciones.
Todas estas líneas de actuación se encuadran en cinco grandes
programas de investigación organizados en torno a cinco
Departamentos:• Biología Ambiental. Estudia como los seres vivos interaccionan con
el medio ambiente que les rodea, incluyendo la relación de las plantas
con el medio biótico y abiótico, nuevas estrategias para el control
de plagas o la utilización de microorganismos y sus enzimas para el
desarrollo sostenible de aplicaciones industriales y medioambientales.
• Biología Celular y Molecular. Estudia dos aspectos diferentes y
complementarios de los procesos de identidad y regulación celular
en procariotas y eucariotas: i) bases moleculares de la unidad celular
y su integración en tejidos y órganos y ii) aproximaciones sintéticas
“bottom-up” para el diseño y microfabricación de componentes que
permitan nuevas funcionalidades de las células.
• Biología Físico-Química. Trata de entender problemas biológicos
específicos, a distintos niveles de complejidad, a través de la química
y la física de las proteínas y otras moléculas biológicas, con el fin
de predecir funciones esenciales y poder proponer aplicaciones
biomédicas y/o biotecnológicas.
• Medicina Celular y Molecular. Su objetivo es comprender las
bases moleculares de diferentes patologías humanas, enfermedades
raras o comunes con gran repercusión en la sociedad, para
desarrollar estrategias que ayuden a diseñar nuevas terapias
combinando estudios genéticos, celulares y estructurales.
• Microbiología Molecular yBiología de la Infección. Se ocupa
de una manera singular de desarrollar estrategias originales para el
tratamiento de enfermedades producidas por microorganismos, tras
conocer los mecanismos moleculares que controlan estas infecciones.
Por otro lado, es preciso destacar que el CIB está dotado de un
gran número de Servicios Científicos especializados (animalario,
citometría de flujo, cromatografía de gases, microscopía electrónica
y confocal, secuenciación de ADN y péptidos, proteómica y
genómica, resonancia magnética nuclear de biomoléculas, síntesis
de péptidos u oligonucleótidos y ultracentrifugación analítica), con
personal altamente cualificado, que además de prestar apoyo a
los investigadores de este Centro y del CSIC, dan cobertura a otros
Centros de Investigación (públicos o privados), Universidades y
empresas. También contamos con una excelente biblioteca, que
cuenta con uno de los fondos bibliográficos más importantes de
Europa en el ámbito de la Biología y Biomedicina, y con una red de
servicios de apoyo a la investigación que incluye administración,
gerencia, cultivos celulares, esterilización, informática, protección
radiológica y la unidad de servicios técnicos e infraestructuras.
Finalmente, comentar que la multidisciplinaridad es uno de los
grandes valores de nuestro Centro, permitiendo la integración de
metodologías y aproximaciones experimentales distintas, en un
momento en el que se hace evidente que, dada su complejidad,
los procesos biológicos solo se pueden comprender mediante
aproximaciones distintas y complementarias. Pero este valor se
convierte en un reto en las actuales circunstancias, puesto que
mantener la competitividad en áreas técnicas y científicas muy
diversas exige una adaptación constante a los avances tecnológicos
y una renovación y modernización continua de los grandes equipos.
A pesar de la difícil situación actual, con una reducción de fondos
importantes, el CIB cuenta con un gran número de profesionales
expertos en áreas muy diversas, que apuestan por afrontar juntos
los retos actuales y futuros para seguir siendo un centro de
referencia nacional e internacional.DIRECTOR'S REPORT: The Biological Research Centre (CIB) is one of the most
prestigious research centres of the Spanish National
Research Council (CSIC), and has been at the forefront
of biological research since its creation in 1953. The
initial activity of the CIB focused primarily on studies in the fields of
biology and biomedicine, but currently the CIB is a multidisciplinary
centre, bringing together researchers in the areas of biology,
agricultural sciences and chemistry. It is an active, dynamic centre in
constant evolution.
During its long history, the CIB has trained and supported
outstanding researchers who have been the driving force behind
the formation of other top centres such as the Severo Ochoa
Molecular Biology Centre, the Cajal Institute, and the Alberto Sols
Molecular Biology Centre in Madrid, the Institute of Biology and
Photosynthesis in Seville, and the Institute of Microbiology and
Biochemistry in Salamanca. At present, the CIB is constituted by
approximately 560 professionals including staff researchers, contract
researchers, scholarship and PhD students, as well as administrative
and maintenance personnel.
The CIB is currently located within the campus of Madrid’s
Complutense and Politécnica Universities, surrounded by the
Faculties of Biology, Physics, Chemistry, Pharmacy and Medicine,
as well as the Schools of Forestry and Agronomy. This places it
in a unique setting for collaboration with academic researchers,
participating in undergraduate and graduate courses and in
the training of young scientists and qualified technicians. The
multidisciplinary character of the CIB has made it a recognised
centre for the training of new scientists and technicians qualified for
inclusion in high caliber academic and industrial laboratories.
Funding for research conducted at CIB is obtained from different
agencies, both national and international, through competitive
funding programs and contracts with companies. Furthermore, the
CIB carries out an important role in knowledge and technology
transfer, making available to the society the scientific results through
the generation of patents that reflect CIB achievements in different
fields, such as the design of new therapeutic approaches, vaccines,
biological tests or procedures for biotechnological or industrial
development. Moreover, CIB has created two technology-based
spin-off companies to foster the technological development
of this research. All these studies are part of five major research
programmes organised around five departments:• Environmental Biology. It focuses in the understanding on how
living organisms interact and respond to the environment, including
studies on plants and their abiotic and biotic milieu, management
of insect pest populations or the use of microorganisms and
their enzymes for the sustainable development of industrial and
environmental applications.
• Cellular and Molecular Biology. It investigates two different and
complementary aspects concerning the identity and regulation
of prokaryotic or eukaryotic cells: i) Molecular basis of cell
development and its integration in specialized cell types, tissues
and organs and ii) synthetic approximations “bottom-up” for the
design and micro-production of new cell components with new
functionality.
• Chemical and Physical Biology. Its main research goal is to
develop a quantitative understanding of specific biological
problems at different levels of complexity through the physics and
chemistry of proteins and other biological molecules, to predict
essential biological functions and to design biomedical and/or
biotechnological applications.
• Cellular and Molecular Medicine. Its goal is to understand the
molecular mechanisms involved in human physiopathology, rare
or common illnesses with high social impact, to develop strategies
to design new therapies on the basis of genetic, cellular and
structural studies.
• Molecular Microbiology and Infection Biology. It studies the
characterization of the molecular processes that control the life
cycle and functions of microorganisms, as well as the molecular
mechanisms involved in the regulation of microorganism-host
interactions.
The CIB is equipped with a large number of specialized scientific
services (animal facility, flow cytometry, gas chromatography,
electronic and confocal microscopy, DNA and peptide sequencing,
proteomics, nuclear magnetic resonance of biomolecules, peptide
or oligonucleotide synthesis and analytical ultracentrifugation)
with highly qualified personnel, that besides helping researchers
of this centre and the CSIC are also available to other research
centres (public or private) universities, and companies. We can
also count on an excellent library, with one of the most important
bibliographical collections in Europe in the area of cellular biology
and biomedicine, together with a network of research support
services that includes administration, management, cellular cultures,
sterilization, computer science and radiological protection along
with the technical service and infrastructure unit.
The multi-disciplinary character of our centre is one of its great
assets, facilitating the integration of different methodologies and
experimental approaches at a time when it has become clear that,
given their complexity, biological processes can only be understood
through such distinct complementary approaches. However, under
present circumstances this asset has become a challenge, since
maintaining competitiveness in very diverse technical and scientific
areas requires a constant adaptation to new technological advances
and a continual renewal and update of highly sophisticated
instrumentation. Despite the difficult current situation, with
important reductions in funding, the CIB can count on a large
number of professionals who are experts in very diverse fields, who
are committed to facing the present and future challenges together
so that the CIB can continue to be an important reference centre
both nationally and internationally.Peer reviewe
Recommended from our members
Cyclin A2 modulates kinetochore–microtubule attachment in meiosis II
Cyclin A2 is a crucial mitotic Cdk regulatory partner that coordinates entry into mitosis and is then destroyed in prometaphase within minutes of nuclear envelope breakdown. The role of cyclin A2 in female meiosis and its dynamics during the transition from meiosis I (MI) to meiosis II (MII) remain unclear. We found that cyclin A2 decreases in prometaphase I but recovers after the first meiotic division and persists, uniquely for metaphase, in MII-arrested oocytes. Conditional deletion of cyclin A2 from mouse oocytes has no discernible effect on MI but leads to disrupted MII spindles and increased merotelic attachments. On stimulation of exit from MII, there is a dramatic increase in lagging chromosomes and an inhibition of cytokinesis. These defects are associated with an increase in microtubule stability in MII spindles, suggesting that cyclin A2 mediates the fidelity of MII by maintaining microtubule dynamics during the rapid formation of the MII spindle
Recommended from our members
The ubiquitous microtubule-associated protein 4 (MAP4) controls organelle distribution by regulating the activity of the kinesin motor.
Regulation of organelle transport by molecular motors along the cytoskeletal microtubules is central to maintaining cellular functions. Here, we show that the ubiquitous tau-related microtubule-associated protein 4 (MAP4) can bias the bidirectional transport of organelles toward the microtubule minus-ends. This is concurrent with MAP4 phosphorylation, mediated by the kinase GSK3β. We demonstrate that MAP4 achieves this bias by tethering the cargo to the microtubules, allowing it to impair the force generation of the plus-end motor kinesin-1. Consistent with this mechanism, MAP4 physically interacts with dynein and dynactin and, when phosphorylated, associates with the cargo-motor complex through its projection domain. Its phosphorylation coincides with the perinuclear accumulation of organelles, a phenotype that is rescued by abolishing the cargo-microtubule MAP4 tether or by the pharmacological inhibition of dynein, confirming the ability of kinesin to inch along, albeit inefficiently, in the presence of phosphorylated MAP4. These findings have broad biological significance because of the ubiquity of MAP4 and the involvement of GSK3β in multiple diseases, more specifically in cancer, where the MAP4-dependent redistribution of organelles may be prevalent in cancer cells, as we demonstrate here for mitochondria in lung carcinoma epithelial cells
Prometaphase APCcdh¹ activity prevents non-disjunction in mammalian oocytes
The first female meiotic division (meiosis I, MI) is uniquely prone to chromosome segregation errors through non-disjunction, resulting in trisomies and early pregnancy loss¹. Here, we show a fundamental difference in the control of mammalian meiosis that may underlie such susceptibility. It involves a reversal in the well-established timing of activation of the anaphase-promoting complex (APC)²,³ by its co-activators cdc20 and cdh1. APCcdh¹ was active first, during prometaphase I, and was needed in order to allow homologue congression, as loss of cdh1 speeded up MI, leading to premature chromosome segregation and a non-disjunction phenotype. APCcdh¹ targeted cdc20 for degradation, but did not target securin or cyclin B1. These were degraded later in MI through APCcdc²⁰, making cdc20 re-synthesis essential for successful meiotic progression. The switch from APCcdh¹ to APCcdc²⁰ activity was controlled by increasing CDK1 and cdh1 loss. These findings demonstrate a fundamentally different mechanism of control for the first meiotic division in mammalian oocytes that is not observed in meioses of other species
Dual-mode regulation of the APC/C by CDK1 and MAPK controls meiosis I progression and fidelity
Female meiosis is driven by the activities of two major kinases, cyclin-dependent kinase 1 (Cdk1) and mitogen-activated protein kinase (MAPK). To date, the role of MAPK in control of meiosis is thought to be restricted to maintaining metaphase II arrest through stabilizing Cdk1 activity. In this paper, we find that MAPK and Cdk1 play compensatory roles to suppress the anaphase-promoting complex/cyclosome (APC/C) activity early in prometaphase, thereby allowing accumulation of APC/C substrates essential for meiosis I. Furthermore, inhibition of MAPK around the onset of APC/C activity at the transition from meiosis I to meiosis II led to accelerated completion of meiosis I and an increase in aneuploidy at metaphase II. These effects appear to be mediated via a Cdk1/MAPK-dependent stabilization of the spindle assembly checkpoint, which when inhibited leads to increased APC/C activity. These findings demonstrate new roles for MAPK in the regulation of meiosis in mammalian oocytes
Securin and not CDK1/cyclin B1 regulates sister chromatid disjunction during meiosis II in mouse eggs
Mammalian eggs remain arrested at metaphase of the second meiotic division (metII) for an indeterminate time before fertilization. During this period, which can last several hours, the continued attachment of sister chromatids is thought to be achieved by inhibition of the protease separase. Separase is known to be inhibited by binding either securin or Maturation (M-Phase)-Promoting Factor, a heterodimer of CDK1/cyclin B1. However, the relative contribution of securin and CDK/cyclin B1 to sister chromatid attachment during metII arrest has not been assessed. Although there are conditions in which either CDK1/cyclinB1 activity or securin can prevent sister chromatid disjunction, principally by overexpression of non-degradable cyclin B1 or securin, we find here that separase activity is primarily regulated by securin and not CDK1/cyclin B1. Thus the CDK1 inhibitor roscovitine and an antibody we designed to block the interaction of CDK1/cyclin B1 with separase, both failed to induce sister disjunction. In contrast, securin morpholino knockdown specifically induced loss of sister attachment, that could be restored by securin cRNA rescue. During metII arrest separase appears primarily regulated by securin binding, not CDK1/cyclin B1